Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Net Cash Flow (2020 - 2025)

Bio Essence has reported Net Cash Flow over the past 6 years, most recently at -$28741.0 for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 130.02% year-over-year to -$28741.0; the TTM value through Dec 2025 reached -$1371.0, down 107.91%, while the annual FY2025 figure was -$1371.0, 107.97% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$28741.0 at Bio Essence, down from $28741.0 in the prior quarter.
  • Over five years, Net Cash Flow peaked at $562629.0 in Q3 2023 and troughed at -$463957.0 in Q4 2023.
  • A 5-year average of $9047.0 and a median of $451.0 in 2022 define the central range for Net Cash Flow.
  • On a YoY basis, Net Cash Flow climbed as much as 244514.1% in 2023 and fell as far as 9560.38% in 2023.
  • Year by year, Net Cash Flow stood at -$26410.0 in 2021, then soared by 121.54% to $5690.0 in 2022, then crashed by 8253.9% to -$463957.0 in 2023, then skyrocketed by 97.31% to -$12495.0 in 2024, then crashed by 130.02% to -$28741.0 in 2025.
  • Business Quant data shows Net Cash Flow for BIOE at -$28741.0 in Q4 2025, $28741.0 in Q3 2025, and -$1371.0 in Q1 2025.